The expression levels of HLA-DR, CD62L and CD95 were reduced in Treg of PB, BM and involved lymphatic tissues from patients with B-cell NHL compared with those from PB samples of HVs and benign LNs. The gene discussed is FAS; the disease is B-cell non-Hodgkin lymphoma.